Profile
Eliahu Heldman was the founder of NeuroDerm Ltd., a company founded in 2003, where he held the title of Chief Scientific Officer.
Currently, Dr. Heldman is the Head-Chemistry Laboratory at Ben-Gurion University of the Negev.
Previously, he worked as a Principal at the National Institutes of Health.
Dr. Heldman's education includes a doctorate from City University of New York and undergraduate and graduate degrees from The Hebrew University of Jerusalem.
Eliahu Heldman active positions
| Companies | Position | Start |
|---|---|---|
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Eliahu Heldman
| Companies | Position | End |
|---|---|---|
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | 1974-12-31 |
| NEURODERM LTD | Founder | - |
Training of Eliahu Heldman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
City University of New York
City University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroDerm Ltd.
NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Eliahu Heldman
















